• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Peptides
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Peptides

Research Brief on (2R)-2-(2-aminoacetamido)pentanoic acid (CAS: 1999-38-8): Recent Advances and Applications

(2R)-2-(2-aminoacetamido)pentanoic acid (CAS: 1999-38-8) is a chiral amino acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has been explored for its potential applications in drug development, peptide synthesis, and as a building block for bioactive molecules. Recent studies have focused on its synthesis, biological activity, and therapeutic potential, making it a subject of interest for researchers in the field.

One of the key areas of research involving (2R)-2-(2-aminoacetamido)pentanoic acid is its role in peptide modification and drug design. The compound's chiral center and functional groups make it a versatile intermediate for the synthesis of peptidomimetics and other bioactive compounds. Recent publications have highlighted its use in the development of novel antimicrobial agents, where its incorporation into peptide sequences has shown enhanced activity against resistant bacterial strains. Additionally, its potential as a modulator of enzyme activity has been investigated, with promising results in preclinical models.

In terms of synthesis, recent advancements have focused on optimizing the production of (2R)-2-(2-aminoacetamido)pentanoic acid to improve yield and purity. Green chemistry approaches, including enzymatic synthesis and solvent-free reactions, have been explored to reduce environmental impact and enhance scalability. These methods not only address the growing demand for sustainable chemical processes but also ensure the compound's suitability for pharmaceutical applications where high purity is critical.

The biological evaluation of (2R)-2-(2-aminoacetamido)pentanoic acid has revealed its potential in targeting specific pathways involved in inflammation and cancer. Studies have demonstrated its ability to inhibit key enzymes such as matrix metalloproteinases (MMPs) and cyclooxygenases (COXs), which are implicated in disease progression. Furthermore, its incorporation into drug delivery systems has been explored to enhance bioavailability and target specificity, offering new avenues for therapeutic intervention.

In conclusion, (2R)-2-(2-aminoacetamido)pentanoic acid (CAS: 1999-38-8) represents a promising compound with diverse applications in chemical biology and pharmaceutical research. Recent studies underscore its potential in drug development, peptide engineering, and sustainable synthesis. Continued research into its mechanisms of action and therapeutic applications is expected to yield further insights and innovations in the field.

• 1946-82-3(Na-Acetyl-L-Lysine)
• 3303-34-2(L-Alanyl-L-leucine)
• 1188-37-0(N-Acetyl-L-glutamic acid)
• 869-19-2(Glycyl-L-leucine)
• 25988-63-0(Poly-L-lysine hydrobromide (MW 150000-300000))
• 19146-55-5(N-Acetyl-D-glutamic Acid)
• 19461-38-2(N-Glycyl-L-isoleucine)
• 13115-71-4(Glycyl-glutamine)
• 2490-97-3(Aceglutamide)
• 5817-08-3(2-Acetamidopentanedioic acid)